Leaflet MISODEL 200mcg vaginal delivery system


Indicated for: gastric ulcer prevention; obstetric indications

Route of administration: vaginal

Substance: misoprostol (vasodilator)

ATC: G02AD06 (Genito urinary system and sex hormones | Uterotonics | Prostaglandins)

Misoprostolum is a medication used for the prevention and treatment of gastric ulcers induced by nonsteroidal anti-inflammatory drugs (NSAIDs), as well as for labor induction or medical abortion. It is a prostaglandin E1 analog and works by protecting the gastric mucosa and stimulating uterine contractions.

The medication is administered orally, vaginally, or sublingually, depending on the indication. It is effective in reducing the risk of complications associated with gastric ulcers and managing complicated pregnancies.

Side effects may include nausea, diarrhea, abdominal cramps, and, in rare cases, severe allergic reactions. Its use must be closely monitored, especially in the context of pregnancy.

Consult your doctor to discuss the benefits and risks of treatment with Misoprostolum. Follow all medical recommendations to ensure the safe use of this medication.

General data about MISODEL 200mcg

  • Substance: misoprostol
  • Date of last drug list: 01-07-2020
  • Commercial code: W60528003
  • Concentration: 200mcg
  • Pharmaceutical form: vaginal delivery system
  • Quantity: 5
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: FERRING CONTROLLED THERAPEUTICS LIMITED - MAREA BRITANIE
  • Holder: FERRING GMBH - GERMANIA
  • Number: 6162/2014/03
  • Shelf life: 3 years

Pharmaceutical forms available for misoprostol

Concentrations available for misoprostol

  • 200mcg
  • 25mcg
  • 400mcg